Inflammatory Responses in Ebola Virus-Infected Patients

Methods of Investigation Inflammatory response in Ebola virus infected patients: patients and outbreaks: In this study, patient specimens (or samples) were collected during two Ebola occurrences. The first occurred in the Mayibout village in February 1996 (located northeast of Gabon). People living there have little access to health resources and have to be admitted to Makuro 7 hours away from us. At some point, 18 of 20 major cases were found to be in contact with dead chimpanzees (assuming Ebola virus infection); apparently they were chopped, cooked and eaten.

In Africa, the most serious haemorrhagic fever has been experienced by Ebola virus (about 28,610 infections were suspected and confirmed between 2014 and 2015, 11,380 people died). Patients were first infected outside of Africa. It is anxiety that another hemorrhagic fever caused by the Marburg virus can enter this potentially lethal area.

Human Ebola hemorrhagic fever is a serious systemic disease caused by Ebola virus infection. Ebola has four subtypes (Ebola - Zaire, Ebola - Sudan, Ebola - Ivory Coast, Ebola - Reston). These are not only single virus variants, but also four viruses Three of these subtypes are known to cause disease in humans, which are subtypes of Zaire, Sudan and the Ivory Coast is. Among all the different viral hemorrhagic fever known to occur in humans, those caused by filoviruses are associated with the highest case mortality rate. These percentages of epidemic hemorrhagic fever caused by Ebola Zaire virus can reach up to 90%. There is no vaccine capable of preventing filovirus infection and there is no specific treatment (CDC II)

Essay.com/World is fighting microorganisms. How to abolish drug abuse, environmental impact, disease and increase resistance

The world is fighting microorganisms. How to abolish drug abuse, environmental impact, disease and increase resistance

Like many serious infections, Ebola virus infections can also cause massive release of inflammatory mediators and vasoactive substances. Even if a proinflammatory mediator promotes inflammation and blood coagulation, it does not effectively control systemic expansion of the infection. This may be due to vasoactive mediation vasodilation. The virus invades endothelial cells and endocardial cells and causes injury (18). This causes internal bleeding, imbalance between fluids and electrolytes, and cardiovascular disorders. Endothelial injury results in platelet aggregation and depletion. Increased levels of proinflammatory factors and production of surface tissue factor proteins in infected monocytes and macrophages promote the clotting cascade. Production of clotting factors, fibrinogen, protein C and S are also reduced due to hepatocellular injury. This can cause diffuse intravascular coagulation.